Chargement en cours...
Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications
The appearance of tyrosine kinase inhibitors (TKIs) has been a major breakthrough in renal cell carcinoma (RCC) therapy. Unfortunately, a portion of patients with TKIs resistance experience disease progression after TKIs therapy. Epigenetic alterations play an important role in the development of TK...
Enregistré dans:
| Publié dans: | Front Genet |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835797/ https://ncbi.nlm.nih.gov/pubmed/33510766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.562868 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|